180 Life Sciences ROCE
Что обозначает ROCE в 180 Life Sciences?
ROCE 180 Life Sciences Corp. является 14,186.55%
Какое определение для ROCE?
Рентабельность использованного капитала (ROCE) - это финансовый коэффициент, который измеряет прибыльность компании и эффективность использования ее капитала.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE компаний в Health Care сектор на NASDAQ по сравнению с 180 Life Sciences
Что делает 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Компании с roce похож на 180 Life Sciences
- Blue Apron Inc имеет ROCE из 5,016.13%
- ParkerVision имеет ROCE из 5,589.92%
- Asensus Surgical Inc имеет ROCE из 5,861.92%
- Whiting USA Trust II имеет ROCE из 7,251.43%
- Astra имеет ROCE из 7,618.05%
- Kalo Gold имеет ROCE из 8,333.61%
- 180 Life Sciences имеет ROCE из 14,186.55%
- Ideanomics Inc имеет ROCE из 29,881.71%
- Internet Gold - Golden Lines имеет ROCE из 31,538.46%
- Predictiv Ai Inc имеет ROCE из 33,476.12%
- T2 Biosystems Inc имеет ROCE из 56,826.92%
- AMBG имеет ROCE из 145,496.28%
- Woluwe Shopping Center имеет ROCE из 520,618,500.00%